SUMMARY UK-9040, a derivative of the antihistamine triprolidine, is a potent gastric secretory inhibitor. Given orally to dogs it reduced gastric acid, pepsin, and volume output in response to food, insulin, histamine, N-methyl histamine, and pentagastrin. Doses of 6-36 mg/kg administered orally four to five hours before the secretagogues produced a dose-dependant and up to 100% inhibition in the outputs of innervated gastric fistula and denervated Heidenhain pouch. Inhibition was still present 24 hours after administration of UK-9040 but was absent at 48 hours. Blood pressure and pulse rate were not affected. Studies with the electron microscope revealed that the normal ultrastructural responses to gastric secretory stimulation were arrested. UK-9040 showed no cumulative effect, tolerance did not occur, and after withdrawal of the drug the physiological and morphological gastric responses of the parietal cells rapidly returned to normal.
The action of histamine on the gastric parietal cell is not blocked by the classical antihistamines. Four dogs with both gastric fistulas and Heidenhain studies in Pavlov stands. Gastric secretion was pouches were trained to undergo gastric secretory collected in 15 minute fractions. Capsules of UK-9040 were given orally after the dogs had fasted after, administration of a meal of 20 g/kg of standard dog food. A total of seven control studies and 12 studies after administration of UK-9040 were conducted in the four dogs. UK-9040 was given in doses between 7 and 30 mg/kg four hours before administration of the meal.
Insulin
Collections were made from the gastric fistula in each dog 30 minutes before and two hours after an intravenous injection of 0 25 units/kg soluble insulin. A total of 11 control studies, and 13 studies after administration of UK-9040, were conducted in the four dogs. UK-9040 was given in doses of 6 to 36 mg/kg between four and five hours before injection of the insulin.
Histamine
Histamine acid phosphate was infused intravenously in a dose of 2 ,ug/kg-min for 2i hours.
Collections were made from both the gastric fistula and the Heidenhain pouch of each dog for 30 minutes before and during the infusion. Gastric secretion from both the fistula and the pouch maintained a plateau over the period between 30 and 150 minutes after the start of the infusion. A total of 12 control studies and 36 studies after administration of UK-9040 were conducted in the four dogs. UK-9040 was given in doses between 1 and 36 mg/kg at various intervals between one and 48 hours before the infusion of histamine. These studies were designed to assess the duration of action of UK-9040.
N-methyl histamine
These studies were identical with those described above for histamine, except that N-methyl histamine was infused in a dose of 1 ,ug/kg-min. Only three control studies and three studies after administration of UK-9040 were conducted because of the limited supply of N-methyl histamine. UK-9040 was given in a dose of 25 mg/kg four hours before the start of the infusion. Studies of the morphological effects of UK-9040 on the parietal cell were made on gastric mucosal biopsies. These were obtained from the lesser curve of the stomach with a Wood's biopsy tube introduced through the gastric fistula of the dog. Biopsies were taken before administration of either secretagogue or UK-9040, after administration of secretagogue and before UK-9040, and after both secretagogue and UK-9040. UK-9040 was given in a dose of 30 mg/kg three hours before biopsy.
The biopsies were orientated on filter paper and divided. One half was fixed in 10% formalin, routinely processed for light microscopy, and stained with haematoxylin and eosin. The other half was placed in 4% methanol-free formaldehyde freshly prepared from paraformaldehyde and buffered in sodium cacodylate at pH 7-4. The tissue was then processed in Epon 12 and ultrathin sections were stained with lead citrate and uranyl citrate. Sections were examined in an Elmiskop A electron microscope.
In a separate experiment two dogs underwent a further operation in which a loop of the carotid artery was exteriorised and covered by a skin tube. This allowed continuous measurement of both pulse and blood pressure by direct cannulation throughout each study.
Results
The results presented are the mean values for the studies in the four dogs.
GASTRIC SECRETION STUDIES-ACID OUTPUT

Food
Administration of UK-9040 in a dose of 8 mg/kg four hours before the meal caused a 50% inhibition of stimulated gastric acid secretion from the Heidenhain pouch (Fig. 2) . At doses greater than 12-5 mg/kg 100% inhibition was observed.
Insulin A 60 % inhibition of insulin stimulated acid secretion from the gastric fistula was observed with a dose of 6 mg/kg of UK-9040 (Fig. 3) . At doses greater than 12-5 mg/kg inhibition approximating to 100% was observed.
Histamine
The denervated pouch was more sensitive than the innervated stomach to inhibition by UK-9040 of histamine stimulated acid secretion (Figs. 2 and 3) . Thus in the innervated stomach 8 mg/kg of UK-9040 caused approximately 40% inhibition of acid output and 15 mg/kg approximately 80% inhibition. In the denervated pouch these doses produced approximately 50% and 100% inhibition respectively. N-mnethyl histamine In the control studies it was found that N-methyl histamine in a dosage of 1 ,ug/kg-min produced acid outputs comparable with those after histamine in a dosage of 2 pLg/kg-min. Complete inhibition of gastric acid secretion from the innervated stomach and 97% inhibition of gastric acid secretion from the Heidenhain pouch were observed.
Pentagastrin
The denervated pouch was again more sensitive than the innervated stomach to inhibition by UK-9040 of pentagastrin stimulated gastric acid secretion (Figs. 4 and 5) . The dose response curve to pentagastrin may have been shifted to the right in the presence of UK-9040 (Fig. 6 ). Duration of inhibition Significant inhibition of histamine stimulated acid secretion from the gastric fistula was observed within one hour of oral administration of UK-9040 (Fig. 7) .
Maximal inhibition was observed between four and six hours (Fig. 8) . Inhibition of approximately 50% was still present when UK-9040 was administered 24 hours before the histamine infusion, but after 48 hours the drug was no longer effective (Fig. 8) . Inhibition of acid output from the denervated pouch was more marked and more sustained (Fig. 7) (Fig. 9) . After gastric secretory stimulation there was a decrease, or a disappearance, of tubulovesicles and an increase in the size of the intracellular canaliculi and the number of microvilli (Fig. 10) . These changes were independent of the stimulant used. In contrast, in the dogs which had received UK-9040 before stimulation of gastric secretion, 70% of the parietal cells in every biopsy studied failed to show the changes associated with stimulation. Their intracellular structure remained in the resting stage (Fig. 11) . This phenomenon was also independent of the method of stimulation. 
Discussion
An ideal gastric secretory inhibitor should inhibit both acid secretion and volume as well as decreasing pepsin activity. The minimum requirements stipulated by McKenna et al. (1964) for such an agent were that there should be 50% inhibition for at least 30 minutes. UK-9040 easily satisfies these criteria when given orally to dogs; it is a powerful and sustained inhibitor of gastric secretion stimulated by histamine, food, pentagastrin, N-methyl histamine, and insulin. This inhibition is not mediated via a hypotensive action, unlike that of hexamethonium bromide (Caridis and Smith, 1968) . The morphological changes that occurred in the present study after stimulation of the parietal cells are similar to those previously reported (Helander, 1962; Ito and Winchester, 1963; Rosa, 1963; Sedar, 1965; Adkins et al., 1966 Adkins et al., , 1967 Helander and Hirschowitz, 1972) . There was a decrease in the number of tubulovesicles and an increase in the size of the intracellular canaliculi and the number of microvilli (Sedar and Friedman, 1961; Helander, 1964) . Like other authors (Ito, 1961) , we considered the variable appearance of dilated or collapsed canaliculi and circular or tubular vesicles to be a fixation artefact.
UK-9040 prevented thecharacteristicmorphological response to gastric stimulation in 70% of the parietal cells studied. The precise mechanisms of acid secretion are unknown, but one step is the incorporation of the tubulovesicular membrane into the intracellular canaliculi (Leeson, 1973) . This in-corporation gives a greatly increased surface area for ionic exchange in the cell and is a feature of the secretory cells of many animal species (Philpott and Copeland, 1963; Sedar, 1969) .
The effect of UK-9040 at an ultrastructural level is similar to that of other antisecretory agents. For example, the formation of microvilli and subsequent increase in surface area of the canaliculi was similarly inhibited after the administration of 2:4 dinitrophenol, an oxidative uncoupling agent (Vial and Orrego, 1963) , acetazolamide, an inhibitor of carbonic anhydrase (Sedar, 1962) , and glycopyrrolate, an anticholinergic (Posey et al., 1968) . It is not clear what these different types of inhibitory substances have in common, but we postulate that the incorporation of the tubulovesicular membranes into the canaliculi is likely to be one of the final events in secretion of acid, as four unrelated compounds, presumably active at different sites, produce the same ultrastructural effects. The mode of action of UK-9040 remains uncertain and the studies do not resolve the problem of whether acid secretion is mediated solely through histamine (MacIntosh, 1938) or through the interaction of more than one receptor (Grossman and Konturek, 1973 
